Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 3, May

The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

Volume:4   Issue: 3
Pp: 235-256
Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris
DOI: 10.2174/1568009043333032
Published on: 01 March, 2012

The Role of Cytochrome P450 in Cytotoxic Bioactivation: Future Therapeutic Directions

Volume:4   Issue: 3
Pp: 257-265
P. H. Rooney, C. Telfer, M. C. E. McFadyen, W. T. Melvin and G. I. Murray
DOI: 10.2174/1568009043333014
Published on: 01 March, 2012

Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

Volume:4   Issue: 3
Pp: 267-283
X. Chen, S. Wang, N. Wu and C. S. Yang
DOI: 10.2174/1568009043333041
Published on: 01 March, 2012

Retinoids in Cancer Chemoprevention

Volume:4   Issue: 3
Pp: 285-298
Masataka Okuno, Soichi Kojima, Rie Matsushima-Nishiwaki, Hisashi Tsurumi, Yasutoshi Muto, Scott L. Friedman and Hisataka Moriwaki
DOI: 10.2174/1568009043333023
Published on: 01 March, 2012

Targeting Translation for Treatment of Cancer - A Novel Role for IRES?

Volume:4   Issue: 3
Pp: 299-311
Martin Holcik
DOI: 10.2174/1568009043333005
Published on: 01 March, 2012